Recent insider trends for Vascular Biogenics Ltd. (NASDAQ:VBLT) have caught the attention of investors. Patters in insider activity can help analysts formulate an outlook for a stock. In the case of VBLT, the data has a lot to say about how the stock might perform going forward.
Institutions own 07.31% of Vascular Biogenics Ltd. (VBLT)’s shares. The total value of these holdings, in millions, is $16. Among active positions in the latest quarter, 13 holders increased their positions by a total of 154932 shares, 15 holders decreased the positions by a total of 1.21 million shares, and 5 holders held their positions. This works out to a net decrease in ownership of 1.05 million shares, and suggests that institutions are feeling bearish about the stock.
Among new and sold out positions, 8 holders initiated new positions by a total of 92373 shares and 8 holders exited their positions by a total of 579392 shares. This nets out to a decrease of 487019 shares and is another bearish sign for VBLT.
Insider ownership increased by a total of 0 shares, which suggests that VBLT’s key executives are feeling more optimistic about the outlook for the stock. The data from the past twelve months tells a similar story: ownership increased by a net of 0 shares.
Analysts often look at short interest, or the number of shares currently being shorted by investors, to aid in their outlook for a particular stock. Vascular Biogenics Ltd. (NASDAQ:VBLT)’s short interest is 608100 shares, or 7.31% of the float. This represents an increase of 20% in the number of shares being shorted compared to the previous reading, and implies that investors felt more pessimistic about the stock during the past two weeks.
In light of the insider ownership and trading data it makes sense to consider technicals to see if they come to a similar conclusion about the outlook for VBLT. A composite of 13 technical indicators that includes measures such as moving averages and momentum oscillators suggests that VBLT is a Strong buy, which implies that VBLT is expected to outperform the market based on prior trading patterns.
Institutional ownership trends suggest that the stock is cheap and the insider trading data indicates that insiders are bullish. Technical indicators (also) suggest that Vascular Biogenics Ltd. (NASDAQ:VBLT) is undervalued.